Your browser doesn't support javascript.
loading
Kidney Outcomes and Preservation of Kidney Function With Obinutuzumab in Patients With Lupus Nephritis: A Post Hoc Analysis of the NOBILITY Trial.
Rovin, Brad H; Furie, Richard A; Ross Terres, Jorge A; Giang, Sophia; Schindler, Thomas; Turchetta, Armando; Garg, Jay P; Pendergraft, William F; Malvar, Ana.
Affiliation
  • Rovin BH; The Ohio State University Wexner Medical Center, Columbus.
  • Furie RA; Northwell Health, Great Neck, New York.
  • Ross Terres JA; Genentech, Inc, South San Francisco, California.
  • Giang S; Genentech, Inc, South San Francisco, California.
  • Schindler T; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Turchetta A; Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada.
  • Garg JP; Genentech, Inc, South San Francisco, California.
  • Pendergraft WF; Genentech, Inc, South San Francisco, California.
  • Malvar A; Hospital Fernandez, Buenos Aires, Argentina.
Arthritis Rheumatol ; 76(2): 247-254, 2024 02.
Article in En | MEDLINE | ID: mdl-37947366

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Nephritis / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: Arthritis Rheumatol Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Nephritis / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: Arthritis Rheumatol Year: 2024 Document type: Article Country of publication: